1. Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin
- Author
-
Silvia Beatriz Boscardin, Tomoko Ishino, Marcio Massao Yamamoto, Olivier Silvie, Rogerio Amino, Sylvie Dartevelle, François Traincard, Masao Yuda, Raquel Hoffmann Panatieri, Joana Tavares, Eduardo Aliprandini, Sabine Thiberge, Infection et Immunité paludéennes - Malaria Infection and Immunity, Institut Pasteur [Paris] (IP), Instituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto = University of Porto, Instituto de Biologia Molecular e Celular - institute for molecular and cell biology [Porto, Portugal] (IBMC), Department of Parasitology [São Paulo] (IBS), Institute of Biomedical Sciences (ICB/USP), Universidade de São Paulo = University of São Paulo (USP)-Universidade de São Paulo = University of São Paulo (USP), Centre de Production et Infection des Anophèles (plateforme) - Center for the Production and Infection of Anopheles (platform) (CEPIA), Centre d'Immunologie et des Maladies Infectieuses (CIMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Ehime University [Matsuyama, Japon], Mie University Graduate School / Faculty of Medicine [Japan], Mie University, Ingénierie des Anticorps (plate-forme) - Antibody Engineering (Platform), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), This work was supported by funds from Institut Pasteur, Paris, the French National Research Agency (grant no. ANR-14-CE16-Im3alaria), the French Government’s ‘Investissement d’Avenir’ program, Laboratoire d’Excellence ‘Integrative Biology of Emerging Infectious Diseases’ (grant no. ANR-10-LABX-62-IBEID) and ‘ParaFrap’ (grant no. ANR-11-LABX-0024), the São Paulo Research Foundation (FAPESP, grant no. 2014/50631-0), the National Council for Scientific and Technological Development (CNPq), the BNP Paribas CIB, the Portuguese Science and Technology Foundation (FCT, grant no. IF/00881/2012/CP0158) and the European Social Fund (Human Potential Operational Programme)., We thank the team of the Centre of Production and Infection of Anopheles, Institut Pasteur, in particular M. Szatanik, C. Thouvenot, S. Golba, J. Pham and A. Lorthiois for providing mosquitoes and P. falciparum SPZs, the team of the Platform of Dynamic Imaging, Institut Pasteur, in particular Dr S. Shorte and M.-A. Nicola for the access to the confocal microscopes and IVIS system, Dr K. Kim from the Albert Einstein College of Medicine for providing the P. yoelii YM GFP-luciferase, Dr V. Nussenzweig from New York University for providing the P. berghei and falciparumnized P. berghei parasites, Dr M. Soares from the Instituto Gulbenkian for providing the JHT−/− mice, Dr P.-M. Lledo and Dr P. Bruhns from the Institut Pasteur for providing, respectively, the C3−/− and the FcRγ−/− mice, the team of the Clinical Investigation and Access to BioResources, in particular M.-N. Ungeheuer for providing the erythrocytes for the P. falciparum culture, Dr P. Baldacci and Dr P. Formaglio for their critical reading of the manuscript., ANR-14-CE16-0030,IM3alaria,Imagerie et amélioration de la protection immunitaire contre le parasite responsable du paludisme.(2014), ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), ANR-11-LABX-0024,ParaFrap,Alliance française contre les maladies parasitaires(2011), Amino, Rogerio, Appel à projets générique - Imagerie et amélioration de la protection immunitaire contre le parasite responsable du paludisme. - - IM3alaria2014 - ANR-14-CE16-0030 - Appel à projets générique - VALID, Integrative Biology of Emerging Infectious Diseases - - IBEID2010 - ANR-10-LABX-0062 - LABX - VALID, Laboratoires d'excellence - Alliance française contre les maladies parasitaires - - ParaFrap2011 - ANR-11-LABX-0024 - LABX - VALID, Institut Pasteur [Paris], Universidade do Porto, Universidade de São Paulo (USP)-Universidade de São Paulo (USP), Centre d'Immunologie et de Maladies Infectieuses (CIMI), Ehime University [Matsuyama], and Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)
- Subjects
0301 basic medicine ,MESH: Antibodies, Protozoan/pharmacology ,Plasmodium berghei ,[SDV]Life Sciences [q-bio] ,Fc receptor ,Protozoan Proteins ,MESH: Antibodies, Monoclonal/pharmacology ,Antibodies, Protozoan ,Applied Microbiology and Biotechnology ,MESH: Cell Movement/drug effects ,Mice ,MESH: Protozoan Proteins/immunology ,Cell Movement ,MESH: Animals ,MESH: Plasmodium falciparum/immunology ,Skin ,MESH: Pore Forming Cytotoxic Proteins/metabolism ,MESH: Sporozoites/cytology ,biology ,Antibodies, Monoclonal ,3. Good health ,Circumsporozoite protein ,MESH: Sporozoites/immunology ,[SDV] Life Sciences [q-bio] ,[SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology ,Sporozoites ,MESH: Skin/parasitology ,MESH: Plasmodium berghei/immunology ,[SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunology ,MESH: Plasmodium yoelii/cytology ,MESH: Malaria/immunology ,[SDV.IMM]Life Sciences [q-bio]/Immunology ,Female ,Antibody ,Plasmodium yoelii ,Microbiology (medical) ,Pore Forming Cytotoxic Proteins ,[SDV.IMM] Life Sciences [q-bio]/Immunology ,medicine.drug_class ,Immunology ,Plasmodium falciparum ,MESH: Plasmodium yoelii/immunology ,Monoclonal antibody ,complex mixtures ,Microbiology ,03 medical and health sciences ,parasitic diseases ,Genetics ,medicine ,Animals ,MESH: Mice ,fungi ,Cell Biology ,biology.organism_classification ,Malaria ,030104 developmental biology ,Culicidae ,Humoral immunity ,biology.protein ,MESH: Culicidae ,MESH: Female - Abstract
The circumsporozoite protein (CSP) is the major surface protein of malaria sporozoites (SPZs), the motile and invasive parasite stage inoculated in the host skin by infected mosquitoes. Antibodies against the central CSP repeats of different plasmodial species are known to block SPZ infectivity1–5, but the precise mechanism by which these effectors operate is not completely understood. Here, using a rodent Plasmodium yoelii malaria model, we show that sterile protection mediated by anti-P. yoelii CSP humoral immunity depends on the parasite inoculation into the host skin, where antibodies inhibit motility and kill P. yoelii SPZs via a characteristic ‘dotty death’ phenotype. Passive transfer of an anti-repeat monoclonal antibody (mAb) recapitulates the skin inoculation-dependent protection, in a complement- and Fc receptor γ-independent manner. This purified mAb also decreases motility and, notably, induces the dotty death of P. yoelii SPZs in vitro. Cytotoxicity is species-transcendent since cognate anti-CSP repeat mAbs also kill Plasmodium berghei and Plasmodium falciparum SPZs. mAb cytotoxicity requires the actomyosin motor-dependent translocation and stripping of the protective CSP surface coat, rendering the parasite membrane susceptible to the SPZ pore-forming-like protein secreted to wound and traverse the host cell membrane6. The loss of SPZ fitness caused by anti-P. yoelii CSP repeat antibodies is thus a dynamic process initiated in the host skin where SPZs either stop moving7, or migrate and traverse cells to progress through the host tissues7–9 at the eventual expense of their own life. In a rodent malaria model, antibodies against the CSP protein that coats sporozoites lead to Plasmodium yoelii killing in the skin in a process that involves stripping off the CSP coat, rendering parasites susceptible to pore-forming-like proteins.
- Published
- 2018